Research Publications

The management of side-effects during therapy for hepatitis C.

Helminthic infections of the liver.

Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial.

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.

Risks of a range of alcohol intake on hepatitis C-related fibrosis.

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.

Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols.

A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy.